Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

NASDAQ:CRWD - Nasdaq - US22788C1053 - Common Stock - Currency: USD

496.1  +4.03 (+0.82%)

After market: 496.1 0 (0%)

Fundamental Rating

5

Overall CRWD gets a fundamental rating of 5 out of 10. We evaluated CRWD against 282 industry peers in the Software industry. The financial health of CRWD is average, but there are quite some concerns on its profitability. CRWD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CRWD was profitable.
In the past year CRWD had a positive cash flow from operations.
In the past 5 years CRWD reported 4 times negative net income.
Each year in the past 5 years CRWD had a positive operating cash flow.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

CRWD has a Return On Assets (-1.98%) which is in line with its industry peers.
With a Return On Equity value of -4.99%, CRWD perfoms like the industry average, outperforming 57.45% of the companies in the same industry.
Industry RankSector Rank
ROA -1.98%
ROE -4.99%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

CRWD has a Gross Margin of 74.48%. This is in the better half of the industry: CRWD outperforms 64.89% of its industry peers.
In the last couple of years the Gross Margin of CRWD has remained more or less at the same level.
CRWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRWD has been increased compared to 1 year ago.
CRWD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CRWD has been reduced compared to a year ago.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 14.54 indicates that CRWD is not in any danger for bankruptcy at the moment.
CRWD has a Altman-Z score of 14.54. This is amongst the best in the industry. CRWD outperforms 90.78% of its industry peers.
CRWD has a debt to FCF ratio of 0.73. This is a very positive value and a sign of high solvency as it would only need 0.73 years to pay back of all of its debts.
The Debt to FCF ratio of CRWD (0.73) is better than 75.53% of its industry peers.
CRWD has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
CRWD has a Debt to Equity ratio (0.22) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.73
Altman-Z 14.54
ROIC/WACCN/A
WACC8.89%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

CRWD has a Current Ratio of 1.85. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD has a Current ratio (1.85) which is in line with its industry peers.
CRWD has a Quick Ratio of 1.85. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.85, CRWD is in line with its industry, outperforming 57.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.43% over the past year.
Measured over the past years, CRWD shows a very strong growth in Earnings Per Share. The EPS has been growing by 79.46% on average per year.
CRWD shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.94%.
The Revenue has been growing by 52.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)8.43%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-21.51%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%19.8%

3.2 Future

The Earnings Per Share is expected to grow by 17.66% on average over the next years. This is quite good.
CRWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.08% yearly.
EPS Next Y-8.79%
EPS Next 2Y10.68%
EPS Next 3Y16.5%
EPS Next 5Y17.66%
Revenue Next Year21.71%
Revenue Next 2Y21.74%
Revenue Next 3Y22.27%
Revenue Next 5Y22.08%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 133.00, which means the current valuation is very expensive for CRWD.
Compared to the rest of the industry, the Price/Earnings ratio of CRWD is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.21, CRWD is valued quite expensively.
The Price/Forward Earnings ratio is 103.04, which means the current valuation is very expensive for CRWD.
Based on the Price/Forward Earnings ratio, CRWD is valued a bit more expensive than 60.99% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CRWD to the average of the S&P500 Index (21.70), we can say CRWD is valued expensively.
Industry RankSector Rank
PE 133
Fwd PE 103.04
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CRWD's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as CRWD.
Industry RankSector Rank
P/FCF 120.46
EV/EBITDA 4864.75
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as CRWD's earnings are expected to grow with 16.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.68%
EPS Next 3Y16.5%

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (7/2/2025, 4:27:47 PM)

After market: 496.1 0 (0%)

496.1

+4.03 (+0.82%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners73.11%
Inst Owner Change3.76%
Ins Owners3.08%
Ins Owner Change1.54%
Market Cap123.56B
Analysts79.32
Price Target474.5 (-4.35%)
Short Float %3.6%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.96%
Min EPS beat(2)9.3%
Max EPS beat(2)18.62%
EPS beat(4)4
Avg EPS beat(4)11.48%
Min EPS beat(4)5.05%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)12.45%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)21.52%
Revenue beat(2)1
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.53%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-2%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.66%
Revenue beat(12)4
Avg Revenue beat(12)-0.32%
Revenue beat(16)8
Avg Revenue beat(16)0.45%
PT rev (1m)14.96%
PT rev (3m)15.56%
EPS NQ rev (1m)2.8%
EPS NQ rev (3m)2.83%
EPS NY rev (1m)2.39%
EPS NY rev (3m)-19.98%
Revenue NQ rev (1m)-0.93%
Revenue NQ rev (3m)-0.93%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 133
Fwd PE 103.04
P/S 29.87
P/FCF 120.46
P/OCF 89.37
P/B 35.81
P/tB 51.23
EV/EBITDA 4864.75
EPS(TTM)3.73
EY0.75%
EPS(NY)4.81
Fwd EY0.97%
FCF(TTM)4.12
FCFY0.83%
OCF(TTM)5.55
OCFY1.12%
SpS16.61
BVpS13.86
TBVpS9.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.98%
ROE -4.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.48%
FCFM 24.8%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.73
Debt/EBITDA 30.51
Cap/Depr 155.6%
Cap/Sales 8.63%
Interest Coverage N/A
Cash Conversion 5666.88%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 14.54
F-Score4
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.45%
Cap/Sales(3y)9.2%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.43%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-21.51%
EPS Next Y-8.79%
EPS Next 2Y10.68%
EPS Next 3Y16.5%
EPS Next 5Y17.66%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%19.8%
Revenue Next Year21.71%
Revenue Next 2Y21.74%
Revenue Next 3Y22.27%
Revenue Next 5Y22.08%
EBIT growth 1Y-861.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.18%
EBIT Next 3Y37.44%
EBIT Next 5Y36.81%
FCF growth 1Y37.6%
FCF growth 3Y34.28%
FCF growth 5Y143.57%
OCF growth 1Y34.63%
OCF growth 3Y33.96%
OCF growth 5Y69.1%